
Sign up to save your podcasts
Or


Summary
In this episode of the Talking Biotech Podcast, Dr. Matthew Disney discusses the potential of RNA as a therapeutic target, exploring its historical context, pathogenic roles in diseases, and the challenges and innovations in drug design. The conversation delves into specific diseases like myotonic dystrophy, ALS, and various cancers, highlighting the advantages of small molecules in treatment and the future directions of RNA therapeutics.
By Colabra4.8
273273 ratings
Summary
In this episode of the Talking Biotech Podcast, Dr. Matthew Disney discusses the potential of RNA as a therapeutic target, exploring its historical context, pathogenic roles in diseases, and the challenges and innovations in drug design. The conversation delves into specific diseases like myotonic dystrophy, ALS, and various cancers, highlighting the advantages of small molecules in treatment and the future directions of RNA therapeutics.

32,200 Listeners

4,274 Listeners

2,463 Listeners

766 Listeners

1,355 Listeners

521 Listeners

827 Listeners

6,441 Listeners

124 Listeners

334 Listeners

4,179 Listeners

26 Listeners

5,579 Listeners

35 Listeners

21 Listeners